Welcome to the University of Pittsburgh PET Center
The PET Research Center is a world-class facility, most recently famous for producing Pittsburgh Compound B, a revolutionary amyloid imaging agent that detects plaques associated with Alzheimer's disease. GE Healthcare has licensed the compound, which scientists are currently testing in clinical trials. The center remains very active in Alzheimer's disease research, particularly in studying disease progression and pre-symptomatic markers.
To view information videos about PET from Dr. Chet Mathis and Dr. Julie Price, visit the below link.